— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance — — Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers — SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the fourth quarter and fiscal […]
Investment in R&D will extend capabilities of computational platform and support growth of partnered and proprietary programs NEW YORK – Schrödinger, a privately held company revolutionizing drug discovery through advanced molecular simulations, today announced the closing of an $85 million financing to support continued growth and innovation of its computational platform and expansion of its […]
San Francisco, Jan. 4, 2019: SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data- Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest Partners, […]
SOUTH SAN FRANCISCO, Calif.–Verily, an Alphabet company, today announced a $1 billion investment round, led by Silver Lake, as it advances plans on business strategies that are additive and complementary to its current life sciences portfolio. Other new investors in the round include Ontario Teachers’ Pension Plan and other global investment management firms. The capital […]
Today, Samplix announced that the company has been selected by the European Commission among the winners of the prestigious Horizon 2020 – SME Instrument program, obtaining €1.9 million to mature its proprietary Xdrop™ technology. The selection process was highly competitive with more than 1.800 applicants and a success rate of only about 3%. Samplix’ proprietary […]
STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in large-scale PCR-based DNA manufacturing, announced today that on December 26, 2018 it closed its previously announced underwritten public offering (the “Offering”) of an aggregate of 5,500,000 shares of common stock, par value $0.001 per share (the “Common Stock”), […]
SAN FRANCISCO — Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has closed a $5.6M Series B financing round led by Research Corporation Technologies (RCT). The funding will be used to support the promising commercialization of Halo Labs’ Horizon® subvisible particle analysis instrument and the continued development of the company’s product pipeline. The Horizon instrument performs […]
Existing investors contribute an additional $30 million to accelerate tools that will revolutionize genomic research BOULDER, Colo. — Inscripta™, a leading gene-editing technology company, today announced that MAD7, its proprietary CRISPR enzyme, has achieved wide adoption by academic, commercial, and government researchers in its first year of availability. MAD7 was recently recognized by the Scientistmagazine as one of […]
Revenue increased by nine percent to EUR 5.8 billion Semiconductor Manufacturing Technology and Medical Technology drove growth All segments and regions contributed to positive result Research and development expenditures have paid off Revenue increased by 12 percent after currency adjustments STUTTGART/Germany The ZEISS Group is continuing its growth trajectory. In fiscal year 2017/18 (ended on […]
Company will deploy funds to scale its unique targeted single-cell DNA solution for oncology and validation of CRISPR gene editing SOUTH SAN FRANCISCO, Calif. — Mission Bio, Inc., the pioneer in single-cell DNA analysis and precision genomics, today announced it raised $30 million in Series B funding from Agilent Technologies (NYSE: A), Cota Capital, LAM […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
